The relationship between anaesthetic induction agent type or dose and clinical outcome in patients with depression undergoing electroconvulsive therapy (ECT)

ISRCTN ISRCTN83454584
DOI https://doi.org/10.1186/ISRCTN83454584
Protocol serial number N0084132839
Sponsor Department of Health
Funder The North and South Bank Research and Development Consortium (UK)
Submission date
30/09/2004
Registration date
30/09/2004
Last edited
05/12/2014
Recruitment status
No longer recruiting
Overall study status
Completed
Condition category
Mental and Behavioural Disorders
Prospectively registered
Protocol
Statistical analysis plan
Results
Individual participant data
Record updated in last year

Plain English summary of protocol

Not provided at time of registration

Contact information

Dr Godfrey Bwalya
Scientific

Miranda House
Gladstone Street
Hull
HU3 2RT
United Kingdom

Study information

Primary study designInterventional
Study designRandomised controlled trial
Secondary study designRandomised controlled trial
Scientific titleThe relationship between anaesthetic induction agent type or dose and clinical outcome in patients with depression undergoing electroconvulsive therapy (ECT)
Study objectivesIs there a relationship between the effect of a dose or type of anaesthetic induction agent on seizure duration and clinical outcome in patients undergoing electrical convulsive therapy for depression?
Ethics approval(s)Not provided at time of registration
Health condition(s) or problem(s) studiedMental and Behavioural Disorders: Depression
InterventionRandomised 40 subjects to each of the four anaesthetic induction agent groups.
Pre-ECT Hamilton Depression Rating Scale (HAM-D) score. Six sessions of ECT, observed motor seizure during, electroencephalogram (EEG) seizure duration in seconds. Post ECT HAM-D score done 1-2 days following ECT treatment.
Intervention typeProcedure/Surgery
Primary outcome measure(s)

Hamilton Depression Scale scores and data collection forms.

Key secondary outcome measure(s)

Not provided at time of registration

Completion date01/12/2005

Eligibility

Participant type(s)Patient
Age groupNot Specified
SexNot Specified
Target sample size at registration160
Key inclusion criteriaNot provided at time of registration
Key exclusion criteriaNot provided at time of registration
Date of first enrolment01/03/2003
Date of final enrolment01/12/2005

Locations

Countries of recruitment

  • United Kingdom
  • England

Study participating centre

Miranda House
Hull
HU3 2RT
United Kingdom

Results and Publications

Individual participant data (IPD) Intention to shareNo
IPD sharing plan summaryNot provided at time of registration
IPD sharing plan